Why PainReform Ltd (NASDAQ: PRFX) At $1.40 Is Worth Your Money?

PainReform Ltd (NASDAQ:PRFX) does about 499.07K shares in volume on a normal day but saw 194529704 shares change hands in the recent trading day. The company now has a market cap of 3.11M USD. Its current market price is $1.40, marking an increase of 161.68% compared to the previous close of $0.54. The 52 week high reached by this stock is $20.16 whilst the lowest price level in 52 weeks is $0.43.

PainReform Ltd (PRFX) has a 20-day trading average at $0.6081 and the current price is -93.06% off the 52-week high compared with 224.22% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6602 and its 200-day simple moving average is $4.5545. If we look at the stock’s price movements over the week, volatility stands at 28.18%, which decreases to 16.48% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 79.34 to suggest the stock is overbought.

The consensus objective for the share price is $12.00, suggesting that the stock has a potential upside of 88.33% over the period.

The current price level is 130.24%, 112.04%, and -69.26% away from its SMA20, SMA50, and SMA200 respectively, with the PRFX price moving below the 50-day SMA on current market day. PainReform Ltd (PRFX) stock is up 147.74% over the week and 89.16% over the past month. Its price is -91.52% year-to-date and -89.05% over the past year.

The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of 2.88 above consensus estimates by 11.28. The company’s next earnings report forecasts estimating quarterly EPS at -4.74 and -19.74 for whole year.

To reach the target analysts have set, the stock logically needs to grow 88.33 percent from here.

The company has a return on equity of -716.67%. The beta has a value of 0.58.